Regeneron Pharmaceuticals Corporate Presentation 2021

Regeneron Pharmaceuticals presents its corporate overview and pipeline developments as of November 2021. The presentation covers key marketed products including EYLEA, Dupixent, Libtayo, and Praluent, along with pipeline candidates such as REGEN-COV, fasinumab, and oncology programs. Forward-looking statements address regulatory timelines, commercialization strategies, and market opportunities across ophthalmology, immunology, and oncology.